Head to Head Analysis: Titan Medical (NASDAQ:TMDIF) vs. Daxor (NASDAQ:DXR)

Titan Medical (NASDAQ:TMDIF) and Daxor (NASDAQ:DXR) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, dividends, profitability, valuation, earnings, institutional ownership and risk.

Valuation & Earnings

This table compares Titan Medical and Daxor”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Titan Medical	$17.63 million	3.06	$6.95 million	$0.05	9.47
Daxor	N/A	N/A	N/A	N/A	N/A

Titan Medical has higher revenue and earnings than Daxor.

Volatility & Risk

Titan Medical has a beta of 1.26, suggesting that its share price is 26% more volatile than the S&P 500. Comparatively, Daxor has a beta of -0.51, suggesting that its share price is 151% less volatile than the S&P 500.

Profitability

This table compares Titan Medical and Daxor’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Titan Medical	N/A	-82.31%	-51.47%
Daxor	N/A	N/A	N/A

Insider and Institutional Ownership

0.0% of Titan Medical shares are owned by institutional investors. Comparatively, 1.3% of Daxor shares are owned by institutional investors. 0.0% of Titan Medical shares are owned by insiders. Comparatively, 59.0% of Daxor shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Titan Medical and Daxor, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Titan Medical	0	0	0	0	0.00
Daxor	0	0	1	0	3.00

Daxor has a consensus price target of $24.75, indicating a potential upside of 201.09%. Given Daxor’s stronger consensus rating and higher probable upside, analysts plainly believe Daxor is more favorable than Titan Medical.

Summary

Daxor beats Titan Medical on 7 of the 9 factors compared between the two stocks.

About Titan Medical

Titan Medical Inc. operates as a medical technology company. It focuses on the development and licensing of robotic assisted surgical technologies. The company is headquartered in Toronto, Canada.

About Daxor

Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Daxor Corporation is a subsidiary of Estate Of Joseph Feldschuh.